Shu-Yi Yin

Title: Innovations of Shu-Yi Yin in Cancer Treatment

Introduction

Shu-Yi Yin is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the area of tumor metastasis. His innovative approaches aim to improve treatment outcomes for patients suffering from cancer.

Latest Patents

Shu-Yi Yin holds a patent titled "Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis." This patent describes a method for suppressing tumor metastasis by administering an effective amount of a compound of formula (I) to a subject in need. Additionally, it outlines a method of treating cancer that combines an effective amount of a chemotherapy agent with the compound of formula (I). The patent also includes pharmaceutical compositions designed for suppressing tumor metastasis and treating cancer, each containing the compound of formula (I). He has 1 patent to his name.

Career Highlights

Shu-Yi Yin is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work focuses on the intersection of chemistry and oncology, where he explores novel compounds that can enhance cancer treatment efficacy.

Collaborations

Some of his notable coworkers include Ning-Sun Yang and Yueh-Hsiung Kuo, who contribute to the collaborative research efforts in cancer treatment.

Conclusion

Shu-Yi Yin's innovative work in cancer research exemplifies the potential of new compounds in improving treatment strategies. His contributions are paving the way for advancements in the fight against cancer.